











Receptor type CRSsNP group CRSwNP group Tissue or cell type Regulation References 
TLR1 10 patients 20 patients Ethmoid mucosa (not polypoid) Detected (mRNA); same as control                  Lane AP, 2006 [9] 
TLR2 10 patients 20 patients Ethmoid mucosa (not polypoid) Upregulated mRNA                                                                        ↑ Lane AP, 2006 [9] 
30 patients Not given Nasal epithelial cells (in smears) Upregulated mRNA                                                                        ↑ Dong Z, 2005 [10] 
Not known Not known Primary culture of polyp epithelial cells  Detected (protein) Wang J, 2007 [11] 
12 patients 40 patients Polyp tissue Down-regulated mRNA in patients with microbial colonization  ↓ Pitzurra L, 2004 [12] 
30 patients with and without nasal polyp Nasal biopsies No difference in mRNA Claeys S, 2003 [13] 
40 patients 38 patients Sinonasal mucosa or polyp tissue  Upregulated mRNA in patients in CRSwNP                                 ↑ Zhang QI, 2013 [14] 
Not given 8 patients Primary culture of polyp epithelial cells  Upregulated mRNA after airborne fungi activation                      ↑ Shin SH, 2010 [15] 
20 patients 16 patients Ethmoid mucosa  Down-regulation mRNA in CRS                                                   ↓ Detwiller KY,2014 [16]  
31 patients Not given Sinus tissue mRNA and protein level elevated in biofilm-positive  
compared to biofilm negative CRS                                                ↑                                                                 Sun Y, 2012 [17] 
TLR3 12 patients Not known Primary culture of polyp epithelial cells  Upregulated protein expression                                                     ↑ Wang J, 2007 [11] 
Not given 8 patients Primary culture of polyp epithelial cells  Upregulated mRNA after airborne fungi activation                      ↑ Shin SH, 2010 [15] 
TLR4 30 patients with and without nasal polyp Nasal biopsies No difference in mRNA Claeys S, 2003 [13] 
12 patients 40 patients Polyp tissue Down-regulated mRNA in patients with microbial colonization  ↓     Pitzurra L, 2004 [12] 
30 patients Not given Nasal epithelial cells (in smears) Upregulated mRNA                                                                       ↑ Dong Z, 2005 [10] 
Not known Not known Primary culture of polyp epithelial cells  Detected protein Wang J, 2007 [11  
40 patients 38 patients Sinonasal mucosa or polyp tissue Increased expression (mRNA and protein) in CRSwNP              ↑ Decreased expression in CRSsNP group                                      ↓           Zhang QI, 2013 [14] 
31 patients Not given Sinus tissue Increased expression in CRSsNP (mRNA and protein)                ↑                                                           Sun Y, 2012 [17]
     
TLR5, TLR6 10 patients 20 patients Ethmoid mucosa (not polypoid) Detected (mRNA); same as control Lane AP, 2006 [9] 
TLR7 10 patients 20 patients Ethmoid mucosa (not polypoid) Detected (mRNA); same as control Lane AP, 2006 [9] 
40 patients 38 patients Sinonasal mucosa or polyp tissue Increased expression (mRNA and protein) in CRSwNP              ↑           Decreased expression in CRSsNP group                                      ↓                                 Zhang QI, 2013 [14] 
TLR8 10 patients 20 patients Ethmoid mucosa (not polypoid) Detected (mRNA); same as control Lane AP, 2006 [9] 
TLR9 10 patients 20 patients Ethmoid mucosa (not polypoid) Detected (mRNA); same as control; Down-regulated in patients with early recurrence                        ↓ Lane AP, 2006 [9] 
Not given 10(mRNA)+20(protein) patients Pooled NP tissue Upregulated (mRNA and protein)                                                 ↑ Zhao CY, 2011 [18] 
20 patients 16 patients Ethmoid mucosa No difference in mRNA Detwiller KY, 2014 [16] 
18 patients with CF Not given Sinonasal epithelial cells from middle meatus Upregulated                                                                                    ↑ Melvin TA, 2013 [19] 
















Age (year) 43 (25-75) 43 (25-75) 57 (55-64) 33 (26-59)   
Male 11 11 2 6 30 
55 Female 8 6 5 6 25 
Allergic rhinitis 5 4 1 0 10  
Other atopic disease 2 3 2 0 7  
Asthma 4 4 5* ‡ 0 13  
Smoking 0 1 0 0 1  
Systemic steroid < 3 
months 
0 0 0 0 0  
Topical steroid 19 17 7 0 43  
Inhalative steroid 4 4 5 0 13  
Prior ESS (mean) 0.19+0.1 1.59+0.4 + 3.2+1.2 ++ 0   
 
 
CRSsNP: CRS without nasal polyps; CRSwNP: CRS with nasal polyps; ASA(-): aspirin- tolerant; ASA(+): aspirin-sensitive; ESS: Endoscopic Sinus Surgery; *ASA(+) vs 





Table 3A. Relative expression of genes compared to controls and comparison of expressions between CRS subgroups 
 








TLR1 1.703 1.000 1.487 0.626 0.873 0.583 
TLR2 5.472 0.025* 6.594 0.005* 1.199 1.000 
TLR3 1.724 1.000 3.528 0.167 2.066 1.000 
TLR4 1.234 1.000 1.408 0.571 1.141 0.536 
TLR5 1.763 0.327 2.057 0.004* 1.193 0.532 
TLR6 3.342 0.084 2.902 0.038* 0.868 1.000 
TLR7 1.829 0.789 5.219 0.000* 2.853 0.027* 
TLR8 1.580 1.000 3.345 0.000* 2.117 0.008* 
TLR9 1.417 1.000 2.112 0.008* 1.490 0.008* 
TLR10 2.615 0.077 1.922 0.226 0.734 1.000 
CAMP 17.540 0.209 18.415 0.036* 1.049 1.000 
FOXP3 1.609 0.405 2.041 0.001* 1.268 0.149 
LYZ 1.231 1.000 1.568 0.106 1.122 0.483 
LTF 1.644 0.044* 2.128 0.005* 1.294 1.000 
DEFB1 0.954 0.991 2.254 0.001* 2.362 0.036* 
DEFB3 1.580 1.000 1.189 0.443 0.752 1.000 
DEFB104A 1.852 0.608 3.248 0.009* 1.753 0.414 
DEFB102 3.885 1.000 1.249 1.000 0.321 1.000 
TBX21 4.893 0.005* 6.346 0.000* 1.296 1.000 
GATA-3 3.770 0.368 4.696 0.557 1.245 1.000 
 







Table 3B. Expression of proteins compared to controls and comparison of expressions between CRS subgroups 
 
Proteins CRSsNP/Control CRSwNP/Control CRSwNP/CRSsNP 
 p-value p-value p-value 
TLR2 0.009* 0.033* 0.000* 
TLR3 0.000* 0.027* 0.145 
TLR4 0.446 0.002* 0.001* 
TLR5 0.032* 0.449 0.001* 
CAMP 0.029* 0.146 0.094 
LYZ 0.149 0.035* 0.344 
LTF 0.422 0.012* 0.008* 
HBD2 0.258 0.024* 0.020* 
T-bet 0.084 0.082 0.380 
GATA3 0.079 0.038* 0.190 
 





Table 4A. Relative expression of genes compared between aspirin tolerant and intolerant subgroups of patients and controls 
 








TLR1 1.315 1.000 1.779 0.976 1.352 1.000 
TLR2 0.932 1.000 6.199 0.145 6.651 0.018* 
TLR3 3.425 1.000 6.871 0.522 2.006 0.570 
TLR4 0.791 1.000 1.186 1.000 1.499 1.000 
TLR5 0.933 1.000 1.960 0.440 2.100 0.008* 
TLR6 1.271 1.000 3.419 0.582 2.689 0.103 
TLR7 2.001 1.000 8.004 0.005* 4.000 0.005* 
TLR8 0.739 1.000 2.676 0.120 3.620 0.001* 
TLR9 0.725 1.000 1.665 1.000 2.295 0.006* 
TLR10 1.327 1.000 2.329 0.450 1.755 0.877 
CAMP 0.066 1.000 1.536 1.000 23.237 0.039* 
FOXP3 0.846 1.000 1.809 0.500 2.137 0.001* 
LYZ 0.872 0.542 1.403 1.000 1.932 0.068 
LTF 1.873 1.000 3.177 0.074 1.696 0.026* 
DEFB1 0.438 1.000 1.183 0.795 2.695 0.001* 
DEFB3 0.711 1.000 0.924 1.000 1.298 0.622 
DEFB104A 1.051 1.000 3.364 0.707 3.200 0.016* 
DEFB102 0.769 1.000 1.023 1.000 1.329 1.000 
TBX21 1.722 1.000 9.030 0.113 5.241 0.001* 
GATA-3 1.821 1.000 6.792 1.000 3.728 1.000 
 







Table  4B. Expression of proteins compared between aspirin tolerant and intolerant subgroups of patients and controls 
 ASA(+)/ASA(-)CRSwNP ASA(+) CRSwNP/Co ASA(-) CRSwNP/Co 
Proteins p-value p-value p-value 
TLR2 0.204 0.204 0.052 
TLR3 1.000 1.000 0.013* 
TLR4 0.125 0.125 0.000* 
TLR5 0.184 0.184 0.364 
CAMP 0.441 0.441 0.097 
LYZ 0.091 0.091 0.032* 
LTF 0.029 0.029* 0.018* 
HBD2 0.044 0.044* 0.024* 
T-bet 0.039 0.039* 0.141 
GATA3 0.011 0.011* 0.054 
 





Legends to Figures 
 
Figure 1. TLR-2 expression in macrophages. TLR-2 positive macrophages (arrows) in (a) CRSwNP(ASA-) and in (b) CRSwNP(ASA+) 
samples. TLR-2 5x(a); 20x(b). 
 
Figure 2. Lysozyme expression in CRS tissue. Intraepithelial and subepithelial lysozyme positive macrophages (arrows) in CRSwNP(ASA-) /a/ 
and in CRSwNP(ASA+) tissue /b/. Lysozyme. 20x. 
 
Figure 3. Significantly up-regulated genes in CRSsNP and CRSwNP compared to controls. *Significant expression in CRSwNP versus 
CRSsNP (TLR7: 2.853, p=0.027; TLR8: 2.117, p=0.008; TLR9: 1.490, p=0.008; DEFB1: 2.362, p=0.036) 
 
 
 
 
 
 
 
 
